01.09.2017 00:23:00
|
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE
NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Kite Pharma, Inc. ("Kite Pharma" or the "Company") (NASDAQ: KITE) relating to the sale of the Company to affiliates of Gilead Sciences, Inc. (NASDAQ: GILD). As a result of the merger, Kite Pharma shareholders are only anticipated to receive $180.00 in cash in exchange for each share of Kite Pharma.
Click here for more information: http://monteverdelaw.com/investigations/m-a/. It is free and there is no cost or obligation to you.
The investigation focuses on whether Kite Pharma and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company's by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company.
Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.
If you own common stock in Kite Pharma and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-kite-pharma-inc--kite-300512683.html
SOURCE Monteverde & Associates PC

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Gilead Sciences Inc.mehr Nachrichten
20.02.25 |
Handel in New York: So entwickelt sich der NASDAQ 100 am Mittag (finanzen.at) | |
12.02.25 |
NASDAQ Composite aktuell: NASDAQ Composite zum Ende des Mittwochshandels mit Zuschlägen (finanzen.at) | |
12.02.25 |
Angespannte Stimmung in New York: S&P 500 zum Handelsende schwächer (finanzen.at) | |
12.02.25 |
NASDAQ 100 aktuell: NASDAQ 100 liegt schlussendlich im Plus (finanzen.at) | |
12.02.25 |
Freundlicher Handel: NASDAQ 100-Anleger greifen zu (finanzen.at) | |
12.02.25 |
Angespannte Stimmung in New York: S&P 500 am Mittwochnachmittag im Minus (finanzen.at) | |
12.02.25 |
Börse New York: Das macht der NASDAQ Composite nachmittags (finanzen.at) | |
12.02.25 |
Börse New York: S&P 500 verbucht Abschläge (finanzen.at) |
Analysen zu Gilead Sciences Inc.mehr Analysen
Aktien in diesem Artikel
Gilead Sciences Inc. | 104,86 | 0,48% |
|